Since the current understanding of the precise molecular mechanisms of these mutations is limited, there is no efficient method to treat their associated mitochondrial diseases.
Because our understanding of how these mutations affect mitochondria is incomplete, we currently have no way to effectively treat the related mitochondrial diseases.